ArticleJournal of racial and ethnic health disparities2026
Racial and Ethnic Inequities in Managing Prescription Drug Costs Among Older Adults in Medicare.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Access to prescription drugs is a critical issue for adults 65 and older, almost 90% of whom take at least one medication to manage their health. About one in four Medicare beneficiaries has difficulty affording prescription drugs, resulting in delayed and unfilled prescriptions, and the cost burden is higher among non-Hispanic Black and Latino/a adults. We used nationally representative data to evaluate how differences in socioeconomic resources, access to care, health care need, and the use of cost-saving strategies contributed to long-standing racial and ethnic inequalities in prescription cost burden among older Medicare beneficiaries. We used logistic regressions and the Karlson-Holm-Breen decomposition method to quantify the degrees to which each factor accounted for the heightened cost burden among non-Hispanic Black and Latino/a beneficiaries compared to non-Hispanic White beneficiaries. Non-Hispanic White beneficiaries had lower odds of cost burden and higher odds of engaging in cost-saving strategies compared to marginalized groups. Even after controlling for socioeconomic, insurance, and health characteristics, non-Hispanic Black beneficiaries were more likely to experience prescription drug cost burden, and Hispanic or Latino/a beneficiaries were less likely to use cost-saving strategies compared to non-Hispanic White beneficiaries. Socioeconomic inequalities accounted for a large share of the greater cost burden experienced by older non-Hispanic Black and Hispanic/Latino adults. Notably, Hispanic/Latino beneficiaries' lower use of cost-saving strategies was a significant driver of their greater cost burden. Our study highlights how Medicare, a near-universal insurance system for older Americans, still reproduces systemic inequities and threatens the health and financial well-being of many.
Indexed as
Identifiers
40032794What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.